![Mirum Pharmaceuticals, Inc. Website Screenshot](https://storage.googleapis.com/wmc-assets-37ed7b3aea0e5732/UsersData/publicpages/id-3724-date-2020-08-03.png)
http://mirumpharma.com
Mirum Pharmaceuticals, Inc. Company Intro
Chris Peetz is a co-founder of Mirum and has served as president since December 2018 and as chief executive officer since March 2019. Chris has been an entrepreneur-in-residence at Frazier Healthcare Partners since May 2017. Prior to joining Mirum, Chris served as the chief executive officer of
Industry
Healthcare
Mirum Pharmaceuticals, Inc. Headquaters
950 Tower Lane
Foster City,94404
United States
Mirum Pharmaceuticals, Inc. Share price
17 May 2023 13:32 GMT
$25.70
-0.59 (-2.24 %)
Mirum Pharmaceuticals, Inc. Market cap
$980.171 M
WMC RANKING
2024
Mirum Pharmaceuticals, Inc. # 433
BiotechnologyLatest Mirum Pharmaceuticals, Inc. News
12 Feb 2024
Is Mirum Pharmaceuticals Inc (MIRM) a Stock to Watch After Gaining 11.76% This Week?
Mirum Pharmaceuticals Inc (MIRM) stock is up 11.76% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.
12 Feb 2024
Is Mirum Pharmaceuticals Inc (MIRM) a Stock to Watch After Gaining 11.76% This Week?
Mirum Pharmaceuticals Inc (MIRM) stock is up 11.76% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.
12 Feb 2024
Is Mirum Pharmaceuticals Inc (MIRM) a Stock to Watch After Gaining 11.76% This Week?
Mirum Pharmaceuticals Inc (MIRM) stock is up 11.76% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.
WMC Market Score
WMC Market to Revenue Score
Mirum Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Mirum Pharmaceuticals, Inc. | USD | $0 | $129,877 | $-132,492 | $9,802M | 433 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mirum Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Mirum Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Mirum Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Mirum Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Mirum Pharmaceuticals, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Mirum Pharmaceuticals, Inc. | 0 | 0.23 | 0.03 | 0 | 0 | 0 | 0.09 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge